ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,022.21
-0.58%
US Tech 100
17,033.60
0.00%
Dow Jones
37,753.31
-0.12%
Brent Oil
86.235
-0.86%
Bitcoin
61,214.25
-0.12%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Bone Therapeutics Sa (0R55) Quote

Bone Therapeutics Sa

Bone Therapeutics Sa (0R55)

LSE
3.845
0.00
( 0.00% )
Updated: 20:00:00
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.845
Bid
3.75
Ask
3.94
Volume
0.00
0.00 Day's Range 0.00
3.845 52 Week Range 3.845
Market Cap
2.438M
Previous Close
3.845
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
9,379
Shares Outstanding
121,897,000
Dividend Yield
-
PE Ratio
-1.19
Earnings Per Share (EPS)
-0.02
Revenue
316k
Net Profit
-2.04M

About Bone Therapeutics Sa

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.bonetherapeutics.com
Headquarters
Mont-saint-guibert, Walloon Brabant, Bel
Founded
1970
Bone Therapeutics Sa is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R55. The last closing price for Bone Therapeutics was 3.85 €. Over the last year, Bone Therapeutics shares have traded in a share price range of 3.845 € to 3.845 €.

Bone Therapeutics currently has 121,897,000 shares outstanding. The market capitalization of Bone Therapeutics is 2.44 € million. Bone Therapeutics has a price to earnings ratio (PE ratio) of -1.19.

0R55 Latest News

More News

BioSenic S.A. : Transparency notifications received from François Rieger

BioSenic S.A. : Transparency notifications received from François Rieger   PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings...

3 hours ago
GlobeNewswire Inc.

BioSenic provides further information on its restructuring plan

BioSenic provides further information on its restructuring plan   PRESS RELEASE - PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, 12 April 2024, 12:00 CET – BioSenic (Euronext Brussels...

April 12 2024
GlobeNewswire Inc.

BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global restructuring plan covering the years 2024-2030 to the Enterprise Court of Nivelles

BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global restructuring plan covering the years 2024-2030 to the Enterprise Court of Nivelles PRESS RELEASE - PRIVILEGED...

April 11 2024
GlobeNewswire Inc.

BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions  

BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions     COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 29 mars 2024 à 07h00...

March 29 2024
GlobeNewswire Inc.

BioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World Congress

BioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World Congress PRESS RELEASE Preclinical data in a transgenic mouse...

March 20 2024
UK Regulatory

BioSenic présente des données précliniques concluantes sur son médicament ATO pour le contrôle des principaux symptômes au Congrès mondial 2024 sur la sclérose systémique

BioSenic présente des données précliniques concluantes sur son médicament ATO pour le contrôle des principaux symptômes au Congrès mondial 2024 sur la sclérose systémique COMMUNIQUE DE PRESSE Des...

March 20 2024
UK Regulatory

BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease

BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease INSIDE INFORMATION New data builds on earlier findings...

March 12 2024
UK Regulatory

BioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3

BioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3...

March 12 2024
UK Regulatory

BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions

BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions   COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 29 février 2024 à 07h00 CEST...

February 29 2024
UK Regulatory

BioSenic S.A. : Information on the total number of voting rights and shares

BioSenic S.A. : Information on the total number of voting rights and shares PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 29 February 2024, 7.00 am CEST – BIOSENIC (Euronext...

February 29 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.8453.8453.84517923.845DE
4003.8453.8453.84564203.845DE
12003.8453.8453.84593793.845DE
26003.8453.8453.845117243.845DE
52003.8453.8453.845239163.845DE
156003.8453.8453.845114753.845DE
260003.8453.8453.845112943.845DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.3639
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 59.77
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.82
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.17
(0.00%)
0
AACGATA Creativity Global
$ 0.9747
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.3639
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 59.77
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.82
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.17
(0.00%)
0
AACGATA Creativity Global
$ 0.9747
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.3639
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 59.77
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.82
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.17
(0.00%)
0
AACGATA Creativity Global
$ 0.9747
(0.00%)
0

Discussion

View Full Feed
Investor2014 Investor2014 3 minutes ago
Anavex have only a Strategic AI Partnership, which isn't doing anything as far we can tell.

https://www.anavex.com/post/anavex-life-sciences-and-partex-group-announce-strategic-partnership
AVXL
TRUSTUNITS1000000 TRUSTUNITS1000000 3 minutes ago
0.0015
MJNA
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
Shares outstanding scary 😧
FNRC
Horseb4CarT Horseb4CarT 5 minutes ago
Or just abruptly go black like the last scene of the Sopranos?
NWBO
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
Nasdaq lol🌝
TGGI
TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
What going on ???????
FMNJ
Wayne R Wayne R 8 minutes ago
At last count, no.

Maybe they should auction one off to see if it is worth more than scrap value....
MULN
TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
0.0001
FMNJ
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutes ago
Can’t bother to call, wonder about this company
RVVTF
palaypu0406 palaypu0406 11 minutes ago
If you dare, put your name, and once your name is put, I will take no time to list the staff names here in public domain taking oath from you in confidentiality and no harm -- dare put your name now, and it will tell public whether you are my father in business or a moron,
ITUP
TRUSTUNITS1000000 TRUSTUNITS1000000 11 minutes ago
Interesting company
SBFM
TRUSTUNITS1000000 TRUSTUNITS1000000 13 minutes ago
Interesting
FNMA
bbotcs bbotcs 14 minutes ago
VTLE is one of my dumbest investments of all time.
PaladinOcean33 PaladinOcean33 14 minutes ago
I am your father in term of business
Show me 69 team first
ITUP
TRUSTUNITS1000000 TRUSTUNITS1000000 15 minutes ago
Buzzy where are you
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 16 minutes ago
Interesting cash balance
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 16 minutes ago
Shareholders post
VGID
jxyzobrien jxyzobrien 17 minutes ago
stan harley and tim ord
see bottom soon
min 27

https://www.youtube.com/watch?v=otjnUIQutIA
TRUSTUNITS1000000 TRUSTUNITS1000000 19 minutes ago
Could not find a single diamond
DMDD
TRUSTUNITS1000000 TRUSTUNITS1000000 20 minutes ago
David Lazar take this over
DMDD
TRUSTUNITS1000000 TRUSTUNITS1000000 20 minutes ago
David Lazar take this over
DMDD
TRUSTUNITS1000000 TRUSTUNITS1000000 21 minutes ago
Shareholders post
DMDD
TRUSTUNITS1000000 TRUSTUNITS1000000 22 minutes ago
Not many shares outstanding
DMDD

Your Recent History

LSE
0R55
Bone Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved